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A monoclonal antibody against cytokine-induced
neutrophil chemoattractant attenuates injury in
the small intestine in a model of ruptured
abdominal aortic aneurysm
Ebenezar M. Mbachu, PhD, Lazar V. Klein, MD, Barry B. Rubin, PhD, FRCS(C), and Thomas F.
Lindsay, MDCM, FRCS(C), Toronto, Ontario, Canada
Purpose: Ruptured abdominal aortic aneurysm (RAAA) continues to be a major source of aneurysm-related morbidity and
mortality. Neutrophils have been implicated in RAAA repair–induced organ injury; however, the agents responsible for
neutrophil activation and organ sequestration have not been identified. This study investigated the role of cytokine-
induced neutrophil chemoattractant (CINC) in organ injury in an RAAA model.
Methods: Rats were subjected to 1 hour of hemorrhagic shock with resuscitation, followed by 45 minutes of lower torso
ischemia and 2 hours of reperfusion, and randomly were selected to receive saline solution or anti-rat CINC monoclonal
antibody at the start of hemorrhagic shock. Another group of animals underwent sham operation, and served as a control
group. Intestinal and lung permeability, intestinal and lung myeloperoxidase (MPO) activity, intestinal and lung CINC,
and tumor necrosis factor- (TNF-) levels, resuscitation fluid requirements, and histologic mucosal injury were
evaluated in all groups.
Results: The RAAA model resulted in increased lung and intestinal permeability to radiolabeled albumin and lung MPO
activity (P < .01), with increases in intestinal TNF- (P < .001) and CINC (P < .01) levels, when compared with
sham-operated animals. Treatment with anti-rat CINC monoclonal antibody attenuated the increases in intestinal
permeability and histologic mucosal injury (P < .01), gut TNF- level (P < .001), and resuscitation fluid volume required
(P < .05), without significantly affecting lung and intestinal MPO activity, lung permeability, and intestinal CINC level
(P  NS), compared with animals given saline solution.
Conclusion: Neutralization of CINC by the anti-rat CINC monoclonal antibody attenuated intestinal injury and
induction of intestinal TNF-, but failed to significantly attenuate remote pulmonary injury in this model of RAAA. (J
Vasc Surg 2004;39:1104-11.)
Clinical Relevance. This article describes an intervention to reduce the inflammatory response after RAAA using an
antibody directed against the pro-inflammatory molecule CINC. The model demonstrates the synergy between a period
of hemorrhagic shock and the aortic clamping required to repair a RAAA, which results in systemic lung injury similar to
acute lung injury clinically known as ARDS. The anti-CINC therapy postponed the intestinal injury but did not prevent
the lung injury. The inflammatory response was able to overcome the loss of CINC. For future therapies to be effective
in RAAA patients, they must either have target molecules of critical importance or effector cells (neutrophils) to have the
potential to outwit the multiple redundant pathways that make up the inflammatory response to RAAA.Ruptured abdominal aortic aneurysm (RAAA) is fre-
quently lethal, and accounts for a large percent of the
morbidity and mortality associated with abdominal aortic
aneurysm (AAA).1 After RAAA repair myocardial infarc-
tion, respiratory failure, renal failure, and multiple organ
failure all have been associated with death.2 Enhanced
understanding of the pathophysiologic features of organ
injury after repair of RAAA therefore may lead to the
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potential to reduce organ injury and mortality.
The rupture and repair of an AAA is a combination of
two ischemia-reperfusion events: hemorrhagic shock (HS)
and lower torso ischemia-reperfusion (I/R). At the time of
rupture, HS develops, which has been suggested to be a
form of total body I/R after resuscitation.3 Both RAAA
repair and elective AAA repair require aortic clamping and
declamping, resulting in lower torso I/R during surgical
reconstruction. However, for elective AAA repair infrarenal
aortic clamping results in lower torso ischemia without
previous HS. Both clinical studies and animal investigations
provide evidence that these two events, HS and lower torso
I/R, have a synergistic effect, initiating a systemic inflam-
matory response that results in a high incidence of organ
failure and mortality.4,5
The rat model used in this study simulates RAAA
repair.5-7 A fixed period of HS simulates rupture of the
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atraumatic clips are applied to the abdominal aorta above
the level of the superior mesenteric artery, and subsequent
clip removal results in reperfusion of the ischemic bowel
and lower torso. This rat model of RAAA results in a
consistent significant local (bowel) and remote (lung) in-
jury, which is useful to assess mechanisms responsible for
tissue injury.5-7 HS or aortic clamping alone caused no
significant remote organ injury.5 Our previous studies have
demonstrated that supramesenteric clamping is required to
induce a consistent injury in this model.5 From these stud-
ies and others,8,9 HS has been demonstrated to contribute
to the pathogenesis of tissue injury by priming the inflam-
matory response to a second inflammatory stimulus, fre-
quently termed the “two hit” hypothesis.
Neutrophils are a prime effector mechanism in both HS
and tissue I/R injury,8 and neutrophil-mediated and oxi-
dant-mediated injury in both human beings and animals
after RAAA has been reported.4,5 However, the role of
chemokines in initiating neutrophil activation and seques-
tration has yet to be investigated in RAAA repair.
Interleukin-8 (IL-8) is a C-X-C chemokine and a po-
tent neutrophil chemotactic and activating factor.10,11 It
has a critical role in acute inflammation by recruiting and
activating neutrophils in human beings.11 There has been
no direct homologue of IL-8 in the rat. Cytokine-induced
neutrophil chemoattractant (CINC) is the rat counterpart
of KC/gro protein, but not IL-8 counterpart. However,
CINC is a member of the IL-8 family, being a neutrophil-
specific chemoattractant in vivo.12,13 CINC is a specific
neutrophil chemoattractant and activator in vitro.12,14 A
correlation exists between the degrees of mucosal damage
and the peak level of CINC after reperfusion,15 and CINC
is a potential mediator of the I/R injury in rat small
intestine.15 Anti-rat CINC antibody reduces injury after
intestinal I/R16 and in inflammatory responses that had
previously been primed by HS.9 Fan et al9 demonstrated
that the lung injury elicited by the intratracheal administra-
tion of lipopolysaccharide after HS in the rat was signifi-
cantly improved with anti-rat CINC treatment. Thus we
investigated whether anti-rat CINC antibody reduces the
local intestinal and remote (lung) injuries in our RAAA rat
model.
MATERIAL AND METHODS
Animal surgery. All studies were approved by the
Institutional Animal Care and Use Committee and with the
Guide for the Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources, Commission on Life Sci-
ences, National Research Council National Academy Press.
Washington DC; 1996). Male Sprague-Dawley rats (400-
450 g) that were allowed rat chow and water ad libitum
were pretreated with atropine sulfate (25 g/kg intramus-
cularly) and anesthetized with sodium pentobarbital (50
mg/kg intraperitoneally). The tail vein and right carotid
artery were cannulated for infusion of fluids, for monitoring
systemic blood pressure (mean arterial blood pressure,
MABP), and for blood removal. After performing a trache-otomy, the abdominal aorta was isolated. Both ends of a
5-cm segment of the jejunum were cannulated as described
in a previous study from our laboratory.6 The two cannulas
were exteriorized, and Ringer lactate solution was gently
flushed through them to remove solid particles from the
intestinal segment.6 The intestinal segment was continu-
ously perfused with 37°C Ringer lactate solution at 18
mL/hr with an infusion pump,6 and the abdomen was
sutured closed. The animals then received iodine 125–
albumin (2Ci) via the tail vein catheter for subsequent
permeability studies, and were allowed to stabilize for 30
minutes. HS was induced by blood withdrawal to reduce
and maintain MABP of 50 mm Hg. After 1 hour of HS an
atraumatic clip was applied to the abdominal aorta proximal
to the superior mesenteric artery, after which a second clip
was applied proximal to the iliac bifurcation as quickly as
possible. Between application of the two clips, half of the
shed blood was reinfused through the tail vein catheter.
After 45 minutes of clamping, the clip proximal to the
superior mesenteric artery was removed, and just before
removal of the other clip proximal to the iliac bifurcation
the remainder of the shed blood was rapidly reinfused and
the clip was promptly removed. The abdomen was again
sutured closed, and Ringer lactate solution was infused, as
required, to resuscitate and maintain MABP at 100 mm Hg
during the reperfusion period. Intestinal perfusate was col-
lected from the output cannula every 10 minutes.
Throughout the experiment 0.35-mL blood samples were
withdrawn at the end of shock, clamping, and 1-hour and
2-hour reperfusion. The control group consisted of time-
matched sham-operated animals that underwent the same
preparation, but without the induction of HS or clamping
of the abdominal aorta.
At the end of the experiment the animals were killed
with an intravenous overdose of anesthesia, and bron-
choalviolar lavage (BAL) of the left lung was performed.
Tissues harvested from the small intestine immediately
distal to the perfused gut segment and from the right lung
were immediately frozen in liquid nitrogen and stored at
70°C. Intestinal tissues were preserved in 8% buffered
formalin. The perfused intestinal segment was harvested,
dried at 200°C for 72 hours in an oven, and weighed.
Experimental groups. Rats were randomly assigned
to either sham operation, shock plus clamp (SC) with
intravenous infusion of saline solution, or SC anti-CINC
monoclonal antibody (mAb; SCA) with intravenous
bolus infusion of anti-rat CINC mAb (2 mg/kg) over 1 to
2 minutes at the end of the stabilization period. All groups
contained eight or more rats.
Determination of pulmonary permeability. The
lungs were prepared, and BAL of the left lung was per-
formed as described in previous work.6 The resulting 5 mL
of BAL fluid return and the 1-mL blood sample collected at
the end of the experiment were assayed for 125I activity with
a gamma counter, and relative lung permeability was calcu-
lated as a ratio of total BAL 125I (cpm/mL)/blood 125I
(cpm/mL).6
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dred microliters of serum from each of the collected
0.35-mL blood samples was mixed with 900 L of saline
solution, and 1 mL of each of the final sera and the
intestinal effluents were assayed for 125I activity. A regres-
sion curve was plotted against time with the four serum 125I
counts, and its slope was used to get serum 125I counts at
each 10-minute interval for the entire experiment. Intesti-
nal permeability was measured as intestinal effluent 125I
(cpm/mL)/serum 125I (cpm/mL), and expressed per
gram dry weight of the perfused intestinal segment.
Myeloperoxidase assay. Frozen intestinal and lung
tissues were assayed for myeloperoxidase (MPO) activity
with the method of Suzuki et al17 and as previously report-
ed.6,7 MPO activity was assessed at 37°C by monitoring the
change in absorbance at 655 nm over 3 minutes. The
reaction mixture contained 3,3,5,5-tetramethyl-benzi-
dine in N,N-dimethylformamide in phosphate buffer con-
taining 0.11 mol/L sodium chloride at pH 5.4. The reac-
tion was initiated by the addition of 3 mmol/L of hydrogen
peroxide. One unit of activity was defined as a one-unit
change in absorbance per minute at 37°C. Protein content
of the samples was determined with the protein assay
system (Pierce Chemical, Rockford, Ill). MPO activity was
expressed as units per milligram of protein.6
Histologic assessment of gut injury. The intestinal
specimens that were preserved in 8% buffered formalin were
embedded in paraffin, sectioned, and stained with hema-
toxylin-eosin. Microscopic evaluation of 30 areas per rat
intestinal section was done in a blinded fashion by two
researchers. The sections were graded for mucosal damage
as described by Chiu et al18: grade 0 indicated normal
mucosal villi; grade 1, development of a subepithelial Gru-
enhagen space, usually at the apex of the villus, often with
capillary congestion; grade 2, extension of the subepithelial
space, with moderate lifting of epithelial layer from the
lamina propria; grade 3, massive epithelial lifting down the
sides of villi, with a few denuded villi; grade 4, denuded villi
with lamina propria and dilated capillaries exposed (in-
creased cellularity of lamina propria may be noted); and
grade 5, digestion and disintegration of lamina propria,
hemorrhage, and ulceration.
Intestinal and lung tissue necrosis factor– (TNF-)
quantification. Frozen intestinal and lung samples were
homogenized with the method of Torre-Amione et al.19 In
brief, they were suspended in phosphate-buffered saline
solution (PBS) containing phenylmethylsulfonyl fluoride,
leupeptin, and aprotein. The homogenates were centri-
fuged for 20 minutes at 20,000g. The pellet was solubilized
according to the method of Stauber et al20 by resuspension
in an equal volume of PBS containing phenylmethylsulfo-
nyl fluoride, aprotein, and 1% Triton X-100. After 1 hour of
incubation at 4°C the solubilized protein was centrifuged
for 20 minutes at 20,000g. The supernatant was analyzed in
duplicate with the Cytoscreen rat TNF- enzyme-linked
immunosorbent assay (ELISA) kit (Biosource Interna-
tional, Camarillo, Calif). This assay is linear between 0 and
1000 pg/mL. TNF- levels were standardized to totalsoluble intestinal and lung protein content, determined
with the protein assay (Pierce Chemical),7 and was ex-
pressed in picograms per milligram of tissue protein.
Evaluation of intestinal and lung CINC levels. Fifty
milligrams of the frozen gut and lung tissues were homog-
enized in PBS for 1 minute. The extract was centrifuged at
10000g for 30 minutes, and the supernatant was stored at
70°C until CINC assay.
Measurement of CINC levels in the gut and lung was
performed with the two-step sandwich enzyme immunoas-
say method, with the commercially available GRO/
CINC-1 rat ELISA kit (Amersham Corp, Arlington
Heights, Ill), according to the manufacturer’s instruction.
Intestinal and lung CINC levels were expressed in pico-
grama per milligram of tissue protein. To determine
whether the antibody had any effects on the CINC ELISA,
the assay was also run with standards alone, standards plus
gut tissues collected at the end of the stabilization period,
standards plus gut tissues of antibody-treated sham-oper-
ated rats, and standards plus gut tissues of antibody-treated
SC rats.
Statistical analysis. All data are expressed as mean 
SEM. Statistical analysis of data was performed with analysis
of variance. Significant data were confirmed with a post hoc
comparison among groups, with the Student-Newman-
Keuls test for multiple comparison. P .05 was considered
significant.
RESULTS
MABP. MABP was not different in the three groups
during stabilization. In sham-operated animals MABP re-
mained unchanged throughout the experiment (Fig 1).
During the clamp period MABP was significantly higher in
SCA animals compared with SC animals (Fig 1).
However, during the reperfusion period the MABP in SC
and SCA animals was not different, but was significantly
lower than in sham-operated animals (P  .001; 118.7 
1.4 mm Hg, 101.7 1.9 mm Hg, and 105.4 2.3 mm Hg,
respectively, for sham, SC, and SCA groups; Fig 1).
Lung injury. Lung permeability was significantly in-
creased in saline solution–treated SC animals compared
with sham-operated animals (P .01; Table I). Anti-CINC
mAb attenuated this increase in the SCA group, but
this reduction did not reach statistical significance when
compared with the SC group (Table I). Lung MPO
activity was increased in SC animals compared with sham-
operated animals (P  .01), and treatment with the anti-
body attenuated this increase, although this reduction did
not attain statistical significance (P 	 0.058, SCA vs
SC; Table I).
No significant differences were recorded in the level of
lung TNF- or lung CINC in the treated or nontreated
SC animals compared with sham-operated animals and
between groups (Table I).
Intestinal injury. The time course for the intestinal
permeability index during the reperfusion period is shown
in Fig 2. The intestinal permeability at all 10-minute inter-
vals was significantly increased in saline solution–treated
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CINC mAb attenuated these increases in the SCA
animals, although this attenuation was significant only
within the 40-minute to 110-minute reperfusion phase.
Thereafter (110-minute to 120-minute reperfusion period)
there was no significant difference between SC and
SCA groups in intestinal permeability (Fig 2).
During both the first (0-60 minutes) and second (61-
120 minutes) halves of the reperfusion period, intestinal
permeability was increased in the SC group (P  .01 vs
sham-operated group; Table II). The anti CINC antibody
attenuated this increase in the SCA group, although
this reduction was significant only during the 61-minute to
120-minute reperfusion period (P .01, SCA vs SC;
Table II).
No significant differences were recorded in intestinal
MPO activity in the treated or nontreated SC animals
compared with sham-operated animals and between
Fig 1. Time course (minutes) for mean arterial blood pr
rats were used in the sham-operated group, nine rats in th
 anti–cytokine-induced neutrophil chemoattractant (C
period; C, clamp period; R, reperfusion period. #, P  .
period.
Table I. Lung permeability, MPO activity, TNF-, CINC
Parameter
Sham-operation
group
(n 	 8)
Lung permeability index 0.016  0.002
Lung MPO activity 0.96  0.29
Lung TNF- level 64.31  8.21
Lung CINC level 325.79  15.37
Resuscitation fluid volume 4.1  3.4
MPO, Mycloperopidase; TNF, tumor necrosis factor; CINC, cytokine-induced
*P .01, vs sham group.
†P .001, vs sham group.
§P .05, vs Shock Clamp group.groups. A rise and fall in MPO was observed in the SC
and SCA groups, respectively, compared with the
sham-operated group; however, these differences failed to
achieve statistical significance (Table II).
Intestinal TNF- level. After 120 minutes of reper-
fusion a significant increase in intestinal TNF- level was
observed in saline solution–treated SC animals compared
with sham-operated animals (P .001; Table II). Pretreat-
ment with anti-CINC mAb significantly reduced this in-
crease in the SCA group when compared with the SC
group (P  .001; Table II).
Intestinal CINC level. After 120 minutes of reperfu-
sion, intestinal CINC level was increased in saline solution–
treated SC animals compared with sham-operated ani-
mals (P  .01; Table II). Pretreatment with anti-CINC
mAb had no effect on the level of intestinal CINC, when
compared with saline solution–treated SC animals (P 

.05 vs SC group, but P  .05 vs sham group; Table II).
e (MABP) during entire experimental procedure. Eight
ckClamp group, and nine rats in the ShockClamp
) group. PS, Pre-shock or stabilization period; S, shock
nd ##, P .01, vs Shock  Clamp group during clamp
ls, and total resuscitation fluid volume
Shock  clamp
group
(n 	 9)
Shock  clamp 
anti-CINC group
(n 	 9)
0.107  0.019* 0.068  0.017NS
3.09  0.44† 1.79  0.34NS
66.44  4.76NS 65.90  4.76NS
298.70  20.86NS 336.76  7.14NS
214.9  27.8† 131.2  19.6†§
ophil chemoattractant; NS, not significant, sham vs Shock Clamp group.essur
e Sho
INC
05, aleve
neutr
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in the volume of blood withdrawn during shock in the
saline solution–treated rats (n 	 9) and anti-CINC mAb–
treated rats (n 	 9): 17.8  1.3 mL/kg body weight and
21.3  1.2 mL/kg body weight, respectively (P 
 .05).
Intestinal mucosal injury. There was an increase in
mucosal lesion in SC animals compared with sham-oper-
ated animals (P .001; Table II). Anti-CINC mAb signif-
icantly reduced this increase in SCA animals compared
with saline solution–treated SC animals (P  .01; Table
II).
Representative intestinal sections of sham-operated rats
displayed normal villi, and saline solution–treated SC
animals had a representative villous injury manifested by
Fig 2. Time course for intestinal permeability within 1
sham-operated group, nine rats in the Shock  Clamp g
induced neutrophil chemoattractant (CINC) group. *P
##, P  .01 vs Shock  Clamp group.
Table II. Intestinal permeability, MPO activity, histologic
Parameter
Sham operation
group
(n 	 7)
Intestinal permeability
0–60 min reperfusion 0.090  0.011
61–120 min reperfusion 0.079  0.013
Intestinal MPO activity 3.25  0.6
Intestinal TNF- level 36.1  6.6
Intestinal CINC level 71.2  15.3
Intestinal mucosal injury score 0.00  0.00
MPO, Mycloperopidase; TNF, tumor necrosis factor; CINC, cytokine-ind
group.
*P  .05, vs sham group.
†P  .001, vs Shock  Clamp group.
‡P  .001, vs sham group.
§P  .01, vs sham group.massive epithelial lifting down the sides of the villi and with
a few denuded tips, characteristic of grade 4 injury (pho-
tomicrographs not presented). A representative section of
intestine from SCA animals displayed a reduction in
this mucosal injury, characterized by extension of the sub-
epithelial space, with moderate lifting of epithelial layer
from lamina propria, characteristic of grade 2 injury (pho-
tomicrographs not presented).
Resuscitation fluid requirements. The volume of
fluid given to animals during reperfusion was increased
from 4.1  3.4 mL/kg body weight in sham-operated
animals to 214.9  27.8 mL/kg body weight in saline
solution–treated SC animals (P  .001; Table I). Anti-
CINC mAb therapy significantly reduced this increase to
inute reperfusion period. Seven rats were used in the
, and nine rats in the Shock  Clamp  anti–cytokine-
, and **P .01 vs sham-operated group; #, P .05, and
osal injury, TNF-, and CINC levels
Shock  Clamp
group
(n 	 9)
Shock  Clamp 
anti-CINC group
(n 	 9)
0.771  0.178* 0.358  0.077NS
0.996  0.251* 0.280  0.042NS†
4.31  1.15NS 2.28  0.51NS
122.4  10.1‡ 39.30  6.4NS†
386.20  49.9§ 323.0  52.0*NS
3.95  0.39§ 1.22  0.72NS†
neutrophil chemoattractant; NS, not significant, sham vs Shock  Clamp20-m
roup
.05muc
uced
ock
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 .05 vs SC group; Table I). The time course for the
volume of fluid required to maintain MABP of 100 mm Hg
or greater is seen in Fig 3. From 30 to 120 minutes of
reperfusion the volumes of fluid given at the various 10-
minute intervals were significantly increased in the SC
animals compared with the sham-operated animals (Fig 3).
These increases were significantly attenuated in the
SCA animals only within 30 to 70 minutes of reperfu-
sion (Fig 3). Thereafter, that is, the 70-minute to 120-
minute reperfusion period, there was no significant differ-
ence between the SC and SCA groups in volume of
resuscitation fluid (Fig 3).
DISCUSSION
In addition to the lung and intestinal injury reported
previously in the RAAA model, we have identified signifi-
cant increases in the levels of intestinal chemokines (CINC)
and cytokines (TNF-) in conjunction with mucosal injury.
Anti-rat CINC mAb attenuated increases in intestinal per-
meability, mucosal damage, and TNF- level. The anti-
CINC antibody did not alter intestinal CINC formation.
There was a reduction in resuscitation fluid volume re-
quired; however, remote lung injury was reduced, but not
significantly. The results demonstrate that intestinal CINC
formation in our RAAA rat model contributed to the
production of intestinal TNF-. Thus neutralization of
CINC reduced TNF- production, which resulted in pres-
ervation of the intestinal mucosa histologic features and
prevention of intestinal protein loss. As the duration of
reperfusion increased, intestinal permeability began to in-
crease, suggesting that other mechanisms were activated
and were resulting in progression of the intestinal injury.
Fig 3. Time course for resuscitation fluid requirements d
the sham-operated group, nine rats in the Shock 
anti–cytokine-induced neutrophil chemoattractant (CIN
sham-operated group; #, P  .05, and ##, P  .01 vs ShWithin the duration of the model modulation of the intes-
tinal injury resulted in some improvement in remote lung
permeability and neutrophil sequestration, but this failed to
achieve statistical significance.
As reported elsewhere,10,11 chemokines exhibit actions
that are not just chemotactic. Anti-CINC mAb attenuated
the increase in intestinal TNF- and injury, but did not
reduce intestinal MPO activity. CINC may be acting as an
autocrine activator of neutrophils and mononuclear cells,
to generate more TNF-, rather than acting solely as a
chemotactic factor. CINC neutralization reduced TNF-
production; however, it did not reduce CINC formation.
(We verified that the CINC antibody did not interfere with
the CINC ELISA; data not presented.) Thus the anti-
CINC antibody and that used with the ELISA for quanti-
fication must not compete for similar antigenic sites on the
CINC molecule. We therefore conclude that the effect of
the anti-CINC mAb in our study is likely due to the
functional neutralization of CINC activity in the intestine
rather than to quantitative attenuation or downregulation
of CINC.21
Several possible mechanisms are suggested by the anti-
CINC mAb reduced intestinal permeability. First, by neu-
tralizing CINC action the antibody could have inhibited
the adherence and activation of neutrophils by CINC,
thereby reducing the TNF- level as a result. Anti-rat IL-8
(CINC) mAb treatment in a gut I/R model decreased
plasma TNF- levels significantly 1 hour after reperfusion,
implying that CINC might act as one of the stimulatory
factors in TNF- production in this model.16 By reducing
gut TNF- levels, anti-rat CINC antibody may have inhib-
ited both priming and activation of local intestinal inflam-
matory cells and also those cells passing through the intes-
120-minute reperfusion period. Eight rats were used in
p group, and nine rats in the Shock  Clamp 
roup. b.w., Body weight. *P  .01, and **P  .001 vs
 Clamp group.uring
Clam
C) g
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activity could be ascribed to other neutrophil chemoattrac-
tants other than CINC, such as macrophage inflammatory
protein-2, C5a, CINC-2, CINC-3, and leukotrienes. The
involvement of other chemoattractants may in part explain
the partial rather than complete protection against intesti-
nal injury offered by the anti-CINC antibody. This second
possibility is supported by time course graphs for intestinal
permeability and resuscitation fluid volume (Figs 2 and 3),
that show that the attenuating effects of the antibody are
maximal between 40 and 110 minutes of reperfusion. Dur-
ing the last 40 minutes of reperfusion intestinal permeabil-
ity slowly rises. This suggests that the anti-CINC mAb
might delay injury until the effects of other chemoattrac-
tants progressively come into play. This antibody has been
used in previous investigations at similar dosages. Inasmuch
as CINC, CINC2, and MIP2 share some homologous
sequences, cross-reactivity is a possibility.22 In vitro studies
demonstrate that 30 to 100 times higher concentrations of
the antibody are required to block chemotaxis to CINC2
and MIP2, compared with CINC.23 Thus the primary
effect of the antibody used is neutralization of CINC
effects; however, minor effects against CINC2 or MIP2
cannot be discounted.
The present study differs from previous work6 in that in
this work intestinal MPO activity for sham-operated and
SC animals was similar. One possible reason for this
difference may be that some of the sequestrated neutrophils
in the intestinal tissues of saline solution–treated or anti-
body-treated rats were sloughed off with the intestinal
mucosa and were therefore not able to be measured. This
may have occurred despite proper handling of the gut
samples, which attempted to reduce loss of the sloughed
epithelium during collection and analysis.
From our work, nonetheless, with the simultaneous
increases in intestinal TNF- and CINC levels in SC
animals, we can speculate that leukocytes are activated by
TNF-24 or CINC12,14 to release reactive oxygen species
and proteases,25 which result in endothelial injury and
increased vascular permeability.26
The antibody reduced lung permeability index and
neutrophil sequestration, but this was not statistically sig-
nificant. At 120-minute reperfusion, when BAL was col-
lected, the action of the antibody might have been over-
shadowed by those of other chemoattractants. Our
experimental design, however, did not enable us to mea-
sure lung injury before this time. Intratracheal administra-
tion of the antibody to a “two hit” rat model, involving HS,
and intratracheal administration of lipopolysaccharide sig-
nificantly improved lung permeability.9 In that model the
lipopolysaccharide is administered directly into the lung,
which has been primed with HS. Thus lipopolysaccharide
directly stimulated CINC production in the primed lung,
and CINC neutralization, which was also administered into
the lung directly, attenuated the injury. In the lipopolysac-
charide model, production and neutralization of CINC
occur in the same location. However, in the RAAA two-hit
model there is an increase in intestinal CINC but not lungCINC, which was assessed with a sensitive ELISA. In the
present model, no increase in BAL neutrophils was noted,
compared with intratracheal lipopolysaccharide, in which a
huge increase is expected. This study did not study alter-
ations in CINC messenger RNA levels, as alterations in
CINC protein levels were thought more revelant to infer
physiologic function of the protein in the model. Thus in
the RAAA model systemic administration of anti-CINC
successfully reduced the intestinal injury where CINC ap-
peared to have a direct local action; however, despite similar
tissue levels of anti-CINC in the lung, this injury was
unaffected, and the injury appears to occur via a CINC-
independent mechanism. This may explain why the anti-
body reduced injury in the gut but not in the distant lung.
Our data (Table I; Fig 2) suggest that intestinal injury
after RAAA repair occurs in a biphasic pattern. Specifically,
the early phase of injury (0-40 minutes of reperfusion),
during which anti-CINC mAb did not reduce gut perme-
ability, could be ischemic injury, and the later phase of
injury (41-120 minutes of reperfusion), during which the
antibody reduced gut permeability, likely reflects effects on
the reperfusion phase of injury. Support for this comes from
studies of models of direct I/R of the lung, which have
demonstrated a biphasic local injury.27
Traditionally, either of the following conditions could
lead to a significantly high volume of fluid being given to
animals for resuscitation: increased microvascular perme-
ability, and myocardial dysfunction resulting from the ac-
tion of TNF-.7 The ability of the antibody to reduce gut
permeability may explain the reduced resuscitation fluid
volume in SCA rats. We also noted an increase in gut
TNF- in SC rats, which was attenuated by the antibody
likely secondary to local inhibition. TNF- inhibition im-
proves cardiac function.7,28 Our previous study confirmed
myocardial dysfunction in a RAAA model, although myo-
cardial TNF was not measured in this model.7 The im-
proved MABP during the clamp period in SCA rats may
indicate improved cardiac function. Therefore increased
gut permeability and myocardial dysfunction may in part
account for the increased fluid volume in SC rats. Preven-
tion of the intestinal injury with the CINC mAb may be
sufficient to reduce fluid resuscitation requirements, be-
cause effects on myocardial function remain unknown.
In our study, neither HS nor clamping alone had any
effect on intestinal permeability and resuscitation fluid vol-
ume.6 In contrast, reperfusion after HS and clamping in-
creased these indices of injury. This is consisted with works
using the same rat model, and confirms a two-hit process in
RAAA repair, with HS priming the inflammatory response
to be more susceptible to lower torso I/R.6 We therefore
postulate that part of the injury in RAAA repair may result
from direct or indirect stimulation, or “priming,” of adher-
ent neutrophils by CINC as a result of HS. Priming might
have occurred in resident neutrophils rather than those
recruited into the intestine.
However, other neutrophil chemoattractants, comple-
ments, arachidonate metabolites, and signaling cascades
may have become activated despite CINC neutralization,
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With this built-in redundancy, the lack of one mediator is
easily compensated for, suggesting that the design of ther-
apeutic strategies should be multifactorial.
This two-hit animal model, which includes both HS
and intestinal and lower limb ischemia, cannot completely
mirror clinical practice. In RAAA the duration of HS is
frequently longer than 1 hour, and the incidence of supra-
renal or supraceliac clamping depends on patient factors
and training of the individual surgeon. Thus the degree of
intestinal ischemia and the duration of lower limb ischemia
reperfusion varies considerably among centers and individ-
ual surgeons. While the model cannot account for all
variations in clinical practice, it provides a method for
investigating mechanisms of injury and testing therapy that
cannot be readily tested in human subjects.
In conclusion, our data have identified a role for CINC
in the intestinal injury observed in the two-hit model of
organ injury. In our study the antibody significantly atten-
uated intestinal injury and TNF production, but its effects
on lung injury were not statistically significant. The intes-
tine has long been considered and suggested to be a central
organ of multiple organ failure.29 Consequently, more
studies directed at defining the primary mechanisms that
activate the inflammatory response may lead to the discov-
ery of a therapeutic approach to protect organs after RAAA
and improve survival from this lethal condition.
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